Pretreatment of BM-MSCs improves the survival rate and incidence of DCS. by Chen Lu (135200)

Effect of BM-MSCs in improving DCS induced lung injury. by Chen Lu (135200)

<i>N. parisii</i> infection is not significantly changed in <i>C. elegans</i> sphingolipid biosynthesis mutants. by Hala Tamim El Jarkass (16625309)

Subjects:

Task 1 two-way ANCOVA significant results. by Mucahit Gemici (21519313)

Task 2 one-way ANCOVA significant results. by Mucahit Gemici (21519313)

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”

Unconfined Compressive Strength of Improved Red Clay. by Quan Shen (37564)

Subjects:

The linearly decreasing convergence factor a. by Junhao Wei (6816803)

Forest plot of the improvement in primary endpoints. by Jin-Min Gu (17915039)

Subjects:

Alterations in the composition of gut microbiome in phylum and genus. by Xueyan Lin (448667)

Subjects:

Decreased synthesis of VCAM-1, tubulin and dynein proteins in the heart of mice stimulated with EVs (green) or ICs (blue). by Alberto Cornet-Gomez (10676133)

FBP primarily decreases the protein level of HMGB1 by promoting its lysosomal degradation upon viral infection. by Penghui Hu (695020)

Visualization of heatmaps before and after improvement. by Junyan Wang (4738518)

Subjects:

Comparison of effects before and after improvement. by Junyan Wang (4738518)

Subjects:

Alterations in hematological parameters induced by dimethoate after 90 days. by Nida Saleem (17194610)

Alterations in hematological parameters induced by dimethoate after 60 days. by Nida Saleem (17194610)

Alterations in hematological parameters induced by dimethoate after 30 days. by Nida Saleem (17194610)

Comparison of the Non-healed but Improved DUs Based on Initial Wound Area Size in 2022 vs. 2023. by Heba Tallah Mohammed (2822432)

Subjects: